

CLASSIFICATION: PEPTIDE / CYTOPROTECTIVE AGENT
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL x 2 MG
ACTIVE HALF-LIFE: N/A
DOSAGE: 200–500 MCG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
BPC 157 (Body Protection Compound) by Kalpa Pharmaceuticals is a synthetic pentadecapeptide derived from a protective protein in human gastric juice. It is widely researched for its regenerative and healing properties, particularly in muscle, tendon, ligament, and gut tissues.
Dosages vary depending on goals, but a common protocol is 200–500 mcg/day via subcutaneous injection near the injury site or systemically. Consult with a medical professional for precise application.
Kalpa Pharmaceuticals ensures pharmaceutical-grade peptide quality. Each 2 mL vial contains 5 mg of BPC 157 and is manufactured to meet high purity and sterility standards. For additional peptide and recovery options, browse our Kalpa Pharmaceuticals collection.
This product is intended for research purposes only. It is not FDA-approved for human or veterinary use outside of licensed studies.
BPC 157 is used to support healing of soft tissues such as tendons, ligaments, muscles, joints, and the gastrointestinal tract. It is popular for recovery support.
It is commonly injected subcutaneously, either systemically or near the injury site. Doses range from 200 to 500 mcg daily for 2–4 weeks, depending on goals.
BPC 157 is not FDA-approved for medical use in humans but may be legally purchased for research purposes in many countries, including the United States.
Reported side effects are rare, but may include mild irritation at the injection site or dizziness in sensitive individuals. Always use under medical guidance.
Please log in to write BPC 157 5 MG review.
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: TIRZEPATIDE
FORM: LYOPHILIZED POWDER – 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~5 DAYS
DOSAGE: 2.5 - 5 MG/WEEK (RESEARCH USE ONLY)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: SEMAGLUTIDE
FORM: LYOPHILIZED POWDER – 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: 0.25 - 0.5 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS